John Rogers's GILD Position Overview
John Rogers (via Ariel Investments, LLC) currently holds 205,052 shares of Gilead Sciences, Inc. (GILD) worth $25.17 M, representing 0.27% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, John Rogers has maintained a long-term strategic position in GILD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2020, adding 751,198 shares. Largest reduction occurred in Q4 2022, reducing 1.5 M shares.
Analysis based on 13F filings available since 2013 Q2
John Rogers's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by John Rogers
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -13,726 | Reduce 6.27% | 205,052 | $122.74 |
| Q3 2025 | -150,083 | Reduce 40.69% | 218,778 | $111.00 |
| Q2 2025 | -61,563 | Reduce 14.30% | 368,861 | $110.87 |
| Q1 2025 | +30,630 | Add 7.66% | 430,424 | $112.05 |
| Q4 2024 | +162,746 | Add 68.66% | 399,794 | $92.37 |
| Q3 2024 | -131,363 | Reduce 35.66% | 237,048 | $83.84 |
| Q2 2024 | -374,489 | Reduce 50.41% | 368,411 | $68.61 |
| Q1 2024 | -6,840 | Reduce 0.91% | 742,900 | $73.25 |
| Q4 2023 | -174,247 | Reduce 18.86% | 749,740 | $81.01 |
| Q3 2023 | -215,344 | Reduce 18.90% | 923,987 | $74.94 |
| Q2 2023 | -35,897 | Reduce 3.05% | 1.14 M | $77.07 |
| Q1 2023 | -3,522 | Reduce 0.30% | 1.18 M | $82.97 |
| Q4 2022 | -1.5 M | Reduce 55.92% | 1.18 M | $85.85 |
| Q3 2022 | -43,298 | Reduce 1.59% | 2.67 M | $61.69 |
| Q2 2022 | +78,492 | Add 2.97% | 2.72 M | $61.81 |
| Q1 2022 | +225,340 | Add 9.34% | 2.64 M | $59.45 |
| Q4 2021 | -206,320 | Reduce 7.88% | 2.41 M | $72.61 |
| Q3 2021 | +120,097 | Add 4.80% | 2.62 M | $69.85 |
| Q2 2021 | -334,544 | Reduce 11.80% | 2.5 M | $68.86 |
| Q1 2021 | -144,611 | Reduce 4.85% | 2.83 M | $64.63 |
| Q4 2020 | +375,241 | Add 14.41% | 2.98 M | $58.26 |
| Q3 2020 | +751,198 | Add 40.55% | 2.6 M | $63.19 |
| Q2 2020 | -813,720 | Reduce 30.52% | 1.85 M | $76.94 |
| Q1 2020 | +155,417 | Add 6.19% | 2.67 M | $74.76 |
| Q4 2019 | +20,292 | Add 0.81% | 2.51 M | $64.98 |
| Q3 2019 | -2,401 | Reduce 0.10% | 2.49 M | $63.38 |
| Q2 2019 | +40,695 | Add 1.66% | 2.49 M | $67.56 |
| Q1 2019 | +48,183 | Add 2.00% | 2.45 M | $65.01 |
| Q3 2018 | +74,789 | Add 3.21% | 2.4 M | $77.21 |
| Q2 2018 | +159,941 | Add 7.37% | 2.33 M | $70.84 |
| Q1 2018 | -67,018 | Reduce 3.00% | 2.17 M | $75.39 |
| Q4 2017 | +66,900 | Add 3.08% | 2.24 M | $71.64 |
| Q3 2017 | +78,624 | Add 3.76% | 2.17 M | $81.02 |
| Q2 2017 | +290,612 | Add 16.14% | 2.09 M | $70.78 |
| Q1 2017 | +216,002 | Add 13.63% | 1.8 M | $67.92 |
| Q4 2016 | +51,671 | Add 3.37% | 1.58 M | $71.61 |
| Q3 2016 | +89,223 | Add 6.18% | 1.53 M | $79.12 |
| Q2 2016 | +82,813 | Add 6.09% | 1.44 M | $83.42 |
| Q1 2016 | +46,992 | Add 3.58% | 1.36 M | $91.86 |
| Q3 2015 | +207,006 | Add 18.71% | 1.31 M | $98.19 |
| Q2 2015 | +214,849 | Add 24.10% | 1.11 M | $117.08 |
| Q1 2015 | +88,842 | Add 11.07% | 891,645 | $98.13 |
| Q4 2014 | +158,907 | Add 24.68% | 802,803 | $94.26 |
| Q3 2014 | +5,162 | Add 0.81% | 643,896 | $106.45 |
| Q2 2014 | +241,461 | Add 60.78% | 638,734 | $82.91 |
| Q1 2014 | +72,971 | Add 22.50% | 397,273 | $70.86 |
| Q4 2013 | +259,037 | Add 396.90% | 324,302 | $75.10 |
| Q3 2013 | +53,209 | Add 441.35% | 65,265 | $62.87 |
| Q2 2013 | +12,057 | Add 0.00% | 12,056 | $51.26 |
John Rogers's Gilead Sciences Investment FAQs
John Rogers first purchased Gilead Sciences, Inc. (GILD) in Q2 2013, acquiring 12,056 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Rogers has held Gilead Sciences, Inc. (GILD) for 51 quarters since Q2 2013.
John Rogers's largest addition to Gilead Sciences, Inc. (GILD) was in Q3 2020, adding 2,603,713 shares worth $164.53 M.
According to the latest 13F filing for Q4 2025, John Rogers's firm, Ariel Investments, LLC, owns 205,052 shares of Gilead Sciences, Inc. (GILD), valued at approximately $25.17 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.27% of John Rogers's publicly disclosed stock portfolio, making it one of their key holdings.
John Rogers's peak holding in Gilead Sciences, Inc. (GILD) was 2,978,954 shares, as reported at the end of Q4 2020.